thiazolidines has been researched along with 3,4-dihydroxyphenylacetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, KE; Nielsen, JA | 1 |
| Demarest, KT; Moore, KE; Yamada, K | 1 |
2 other study(ies) available for thiazolidines and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Thyrotropin-releasing hormone and its analog MK-771 increase the cerebroventricular perfusate content of dihydroxyphenylacetic acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cerebral Ventricles; Dose-Response Relationship, Drug; Male; Perfusion; Phenylacetates; Rats; Rats, Inbred Strains; Thiazolidines; Thyrotropin-Releasing Hormone | 1984 |
Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Limbic System; Male; Mesencephalon; Muscle Contraction; Neurons; Rats; Receptors, Dopamine; Substantia Nigra; Thiazolidines; Thyrotropin-Releasing Hormone | 1984 |